Programmable circRNA platform achieves near-complete B cell depletion in non-human primates using targeted in vivo CAR-T deliveryBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage ...
AviadoBio will combine its proprietary vMiX™ RNAi platform with Apertura’s novel human TfR1 capsid (TfR1 CapX™) to enable one ...
Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities -SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...
Sample technologies, QIAcuity and QDI deliver solid growth; QuantiFERON sales affected by significantly lower immigration ...
Toshiba and the National Science Teaching Association (NSTA) honor student innovation with prizes and award ceremony in Washington, D.C.
GARDEN GROVE, CA / ACCESS Newswire / April 27, 2026 / Recovery Beach, a premier detox and residential treatment facility near Anaheim, California, is reopening April 27th with a new Executive Director ...
Coramitug is a potential best-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3Coramitug is being evaluated by Novo Nordisk in the ongoing Phase 3 ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today ...
Witnessing the Full Launch of the "Dual Taiwan-U.S. Production Base" StrategyBURLINGTON, Mass.--(BUSINESS ...
New specialty drug benefits research shows growing focus on medical-benefit drugs, rising interest in trading rebates for ...
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for ...
Approved Single-Dose Oral Treatment for Bacterial Vaginosis and Trichomoniasis —SAN DIEGO--(BUSINESS WIRE)--$EVFM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results